• Japanese
  • Korean
  • Chinese
Cover Image

European Markets for Orthopedic Biomaterials 2014

In Europe, the orthopedic biomaterial market continues to be hampered by the economic difficulties experienced throughout the region; however, favorable demographic trends and the adoption of new products will counteract these market limiters, ultimately supporting modest revenue growth.

Companies Mentioned:

  • Alphatec Spine
  • Anika Therapeutics
  • AorTech International
  • ApaTech
  • Arthrex
  • Athersys
  • Baxter
  • B. Braun
  • Berkeley Advanced Biomaterials
  • Biocomposites
  • Biomatlante
  • Biomet
  • BioMimetic Therapeutics
  • Bioniche Pharma
  • Bioteck
  • BoneSupport
  • Ceramisys
  • Cerapedics
  • CERAVER
  • Croma-Pharma
  • curasan
  • DePuy
  • DJO Global
  • Documedica
  • Exactech
  • Ferring Pharmaceuticals
  • FH ORTHOPEDICS
  • Fidia Farmaceutici
  • Finceramica
  • Galderma
  • Geistlich
  • Genzyme
  • Goodman
  • Inoteb
  • Integra LifeSciences
  • ISTO Technologies
  • Johnson & Johnson
  • Kasios
  • Kyungwon Medical
  • Laboratoires Genevrier
  • Laboratoires Pierre Fabre
  • LCA Pharmaceutical
  • Lifecore Biomedical
  • Mathys AG Bettlach
  • MBA Grupo
  • Medtronic
  • Millenium Biologix
  • Mylan
  • NovaBone
  • NuVasive
  • Olympus
  • Orthovita
  • OSSACUR
  • Osteotech
  • Q-Med
  • Recordati
  • Rottapharm Madaus
  • RTI Biologics
  • Sanofi
  • SBM
  • Seikagaku
  • SIGNUS Medizintechnik
  • Smith & Nephew
  • Stryker
  • Synthes
  • Tecnoss Dental
  • Tedec-Meiji Farma
  • Teknimed
  • TRB Chemedica
  • Wright Medical Technology
  • Zimmer

Table of Contents

TABLE OF CONTENTS

LIST OF FIGURES AND TABLES

EXECUTIVE SUMMARY

1. COUNTRY OVERVIEWS

  • 1.1. France
    • 1.1.1. Demographics and Economy
    • 1.1.2. Health Care System
    • 1.1.3. Regulatory Environment
  • 1.2. Germany
    • 1.2.1. Demographics and Economy
    • 1.2.2. Health Care System
    • 1.2.3. Regulatory Environment
  • 1.3. Italy
    • 1.3.1. Demographics and Economy
    • 1.3.2. Health Care System
    • 1.3.3. Regulatory Environment
  • 1.4. Spain
    • 1.4.1. Demographics and Economy
    • 1.4.2. Health Care System
    • 1.4.3. Regulatory Environment
  • 1.5. UK
    • 1.5.1. Demographics and Economy
    • 1.5.2. Health Care System
    • 1.5.3. Regulatory Environment

2. CLINICAL LANDSCAPE

  • 2.1. Background
    • 2.1.1. Arthritis
  • 2.2. Procedure Descriptions
    • 2.2.1. Bone Graft Procedures
      • 2.2.1.1. Trauma Surgeries
      • 2.2.1.2. Large-Joint Revision and Reconstruction Procedures
      • 2.2.1.3. Thoracolumbar and Cervical Spinal Fusions
      • 2.2.1.4. Craniomaxillofacial Surgeries
      • 2.2.1.5. Extremity Surgeries
    • 2.2.2. Hyaluronic Acid Viscosupplementation Treatments
    • 2.2.3. Interbody Fusions
    • 2.2.4. Cell Concentration System Procedures
    • 2.2.5. Competing Treatments
      • 2.2.5.1. Nonpharmacologic Treatments
      • 2.2.5.2. Nonsteroidal Anti-Inflammatory Drugs
      • 2.2.5.3. Cyclooxygenase-2 Inhibitors
      • 2.2.5.4. Steroid Injections
      • 2.2.5.5. Bariatric Surgery
      • 2.2.5.6. Nonfusion Technologies
      • 2.2.5.7. Additional Competing Treatments for Bone Graft Substitutes

3. PRODUCTS

  • 3.1. Product Descriptions
    • 3.1.1. Bone Grafts
      • 3.1.1.1. Functions
        • 3.1.1.1.1. Autografts
        • 3.1.1.1.2. Demineralized Bone Matrices
        • 3.1.1.1.3. Growth Factors
        • 3.1.1.1.4. Nonproprietary Allografts
        • 3.1.1.1.5. Synthetics
          • 3.1.1.1.5.1. First-Generation Synthetics
          • 3.1.1.1.5.2. Second-Generation Synthetics
        • 3.1.1.1.6. Xenografts
        • 3.1.1.1.7. Orthopedic Stem Cell Products
      • 3.1.1.2. Differentiating Features
    • 3.1.2. Hyaluronic Acid Viscosupplementation Products
      • 3.1.2.1. Functions
      • 3.1.2.2. Differentiating Features
    • 3.1.3. Machined Bone Interbody Devices
      • 3.1.3.1. Functions
        • 3.1.3.1.1. Anterior Lumbar Interbody Fusion
        • 3.1.3.1.2. Posterior Lumbar Interbody Fusion
        • 3.1.3.1.3. Transforaminal Lumbar Interbody Fusion
        • 3.1.3.1.4. Lateral Lumbar Interbody Fusion
        • 3.1.3.1.5. Cervical Interbody Fusion
      • 3.1.3.2. Differentiating Features
    • 3.1.4. Cell Concentration Systems
      • 3.1.4.1. Functions
        • 3.1.4.1.1. Platelet Concentration Systems
        • 3.1.4.1.2. Bone Marrow Aspirate Concentrate Systems
        • 3.1.4.1.3. Bone Marrow Aspirate Systems

4. CLINICAL TRIALS

  • 4.1. Bone Graft Substitute Clinical Trials
    • 4.1.1. Completed Clinical Trials
    • 4.1.2. Ongoing Clinical Trials
  • 4.2. Hyaluronic Acid Viscosupplementation Clinical Trials
    • 4.2.1. Completed Clinical Trials
    • 4.2.2. Ongoing Clinical Trials
  • 4.3. Cell Concentration System Clinical Trials
    • 4.3.1. Completed Clinical Trials
    • 4.3.2. Ongoing Clinical Trials

5. ORTHOPEDIC BIOMATERIAL MARKET

  • 5.1. Market Snapshot
  • 5.2. Detailed Market Analysis
  • 5.3. Competitive Snapshot
  • 5.4. Market Shares
  • 5.5. Recent Events
  • 5.6. Most Promising Emerging Products

6. BONE GRAFT SUBSTITUTE MARKET

  • 6.1. Market Snapshot
  • 6.2. Detailed Market Analysis
    • 6.2.1. By Material
    • 6.2.2. By Procedure Type
  • 6.3. Competitive Snapshot
  • 6.4. Detailed Competitive Landscape
  • 6.5. Market Shares

7. HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

  • 7.1. Market Snapshot
  • 7.2. Detailed Market Analysis
  • 7.3. Competitive Snapshot
  • 7.4. Detailed Competitive Landscape
  • 7.5. Market Shares

8. FRENCH ORTHOPEDIC BIOMATERIAL MARKET

  • 8.1. French Bone Graft Substitute Market Snapshot
  • 8.2. French Hyaluronic Acid Viscosupplementation Market Snapshot
  • 8.3. Market Shares

9. GERMAN ORTHOPEDIC BIOMATERIAL MARKET

  • 9.1. German Bone Graft Substitute Market Snapshot
  • 9.2. German Hyaluronic Acid Viscosupplementation Market Snapshot
  • 9.3. Market Shares

10. ITALIAN ORTHOPEDIC BIOMATERIAL MARKET

  • 10.1. Italian Bone Graft Substitute Market Snapshot
  • 10.2. Italian Hyaluronic Acid Viscosupplementation Market Snapshot
  • 10.3. Market Shares

11. SPANISH ORTHOPEDIC BIOMATERIAL MARKET

  • 11.1. Spanish Bone Graft Substitute Market Snapshot
  • 11.2. Spanish Hyaluronic Acid Viscosupplementation Market Snapshot
  • 11.3. Market Shares

12. UK ORTHOPEDIC BIOMATERIAL MARKET

  • 12.1. UK Bone Graft Substitute Market Snapshot
  • 12.2. UK Hyaluronic Acid Viscosupplementation Market Snapshot
  • 12.3. Market Shares

APPENDIX: METHODOLOGY

APPENDIX: ACRONYMS AND INITIALISMS

APPENDIX: BIBLIOGRAPHY

LIST OF FIGURES AND TABLES

TABLE OF CONTENTS

LIST OF FIGURES AND TABLES

EXECUTIVE SUMMARY

  • Figure 1: Orthopedic Biomaterial Market, by Country, Europe (USD), 2011 - 2017
  • Table 1: Orthopedic Biomaterial Market Landscape, Europe (USD), 2012 and 2017
  • Table 2: Orthopedic Biomaterial Market Leaders, by Product Type and Revenue, Europe, 2012
  • Table 3: Companies Mentioned
  • Table 4: Factors Impacting the Orthopedic Biomaterial Market, by Product Type, Europe, 2012 - 2017
  • Table 5: Recent Novel Devices in the Orthopedic Biomaterial Market, by Brand, Europe, 2012
  • Table 6: Expected Key Events in the Orthopedic Biomaterial Market, Europe, 2012 - 2017
  • Table 7: Key Report Updates
  • Table 8: Geographies Covered, Europe
  • Table 9: Average Currency Exchange Rates
  • Table 10: Orthopedic Biomaterial Procedures Covered, Europe
  • Table 11: Orthopedic Biomaterial Products Covered, Europe

1. COUNTRY OVERVIEWS

  • Table 12: Key Health and Economic Indicators, France
  • Table 13: Key Health and Economic Indicators, Germany
  • Table 14: Key Health and Economic Indicators, Italy
  • Table 15: Key Health and Economic Indicators, Spain
  • Table 16: Key Health and Economic Indicators, UK

2. CLINICAL LANDSCAPE

  • Table 17: Spinal Nonfusions, by Procedure Type

3. PRODUCTS

  • Table 18: Characteristics of Bone Grafts, by Material
  • Table 19: Select First-Generation Synthetic BGS Materials, by Material
  • Table 20: Advantages and Disadvantages of Bone Grafts, by Material
  • Table 21: Advantages and Disadvantages of HA Viscosupplementation Products, by Number of Injections
  • Table 22: Advantages and Disadvantages of IBDs, by Approach

4. CLINICAL TRIALS

  • Table 23: Summary of Promoting Fusion in Minimally Invasive Lumbar Interbody Stabilization with Low-Dose BMP-2 - But What is the Cost?
  • Table 24: Summary of Spine Fusion Instrumented With BMP-2 vs Uninstrumented With Infuse BMP-2 Alone
  • Table 25: Summary of INFUSE Bone Graft/PEEK Interbody Spacer/Anterior Cervical Plate Pivotal Clinical Trial (ACDF)
  • Table 26: Summary of Efficacy and Safety of Accell Evo3 DBM in Instrumented Posterolateral Lumbar Spine Fusion
  • Table 27: Summary of an Assessment of P-15 Bone Putty in Anterior Cervical Fusion With Instrumentation
  • Table 28: Summary of APPRAISET1
  • Table 29: Summary of Comparing Synthetic Bone Alone versus Synthetic Bone With Bone Marrow in Bone Lesions
  • Table 30: Summary of INFUSE Bone Graft in Transforaminal Lumbar Interbody Fusion for Degenerative Disease of Lumbosacral Spine (TLIF)
  • Table 31: Summary of SUPARTZ versus Placebo in Osteoarthritis of the Shoulder Study
  • Table 32: Summary of Three Injections of EUFLEXXA (Sodium Hyaluronate) for Treatment of Chronic Shoulder Pain Associated With Osteoarthritis
  • Table 33: Summary of ORTHOVISC Shoulder RCT (OV Shoulder)
  • Table 34: Summary of A Double-Blind RCT of a Single Dose of Hyaluronan in the Treatment of Osteoarthritis of the Ankle
  • Table 35: Summary of Efficacy of 3 Weekly Injections of Hyaluronate in Patients With Ankle Osteoarthritis
  • Table 36: Summary of Intra-Articular Injection of HA in Symptomatic Osteoarthritis of the Hip
  • Table 37: Summary of Efficacy of Three Weekly Injections of a Bacterial - Sourced Hyaluronate on Pain and Function in Patients With Knee Osteoarthritis
  • Table 38: Summary of Efficacy of Intra-Articular HA in the Knee Osteoarthritis
  • Table 39: Summary of Different Volumes of DUROLANE in Knee Osteoarthritis
  • Table 40: Summary of Comparative Analysis of Intra-articular Injection of Steroid and/or Sodium Hyaluronate in Adhesive Capsulitis
  • Table 41: Summary of Efficacy and Safety of 3 Different Dosage Regimens of HA in Patients with Knee Osteoarthritis
  • Table 42: Summary of Hymovis Versus Placebo in Knee Osteoarthritis
  • Table 43: Summary of EVOKE
  • Table 44: Summary of Growth Factor and Catabolic Cytokine Concentrations Are Influenced by the Cellular Composition of Platelet-Rich Plasma
  • Table 45: Summary of Patellar Tendon Healing With Platelet-Rich Plasma: A Prospective Randomized Controlled Trial
  • Table 46: Summary of Comparative Assessment of Intra-articular Knee Injections of Platelet-rich Plasma (PRP) and Hyaluronic Acid in the Treatment of Knee Osteoarthritis
  • Table 47: Summary of Platelet Rich Plasma (PRP) in Total Knee Replacement
  • Table 48: Summary of Treatment of Acute and Chronic Ligament and Tendon Injuries With Platelet Rich Plasma
  • Table 49: Summary of Use of Platelet Rich Plasma Therapy for Acute Ankle Sprains in the Emergency Department (PRP)
  • Table 50: Summary of Platelet Rich Plasma vs. Corticosteroid Injection in the Treatment of Partial Rotator Cuff Tears
  • Table 51: Summary of Prospective, Multi-Center Clinical Outcomes Study Evaluating the chronOS Strip Combined With Bone Marrow Aspirate

5. ORTHOPEDIC BIOMATERIAL MARKET

  • Figure 2: Orthopedic Biomaterial Market, by Product Type, Europe (USD), 2011 - 2017
  • Table 52: Factors Impacting the Orthopedic Biomaterial Market, by Product Type, Europe, 2012 - 2017
  • Table 53: Orthopedic Biomaterial Market, by Country, Europe (USD, EUR, and GBP), 2011 - 2017
  • Table 54: Orthopedic Biomaterial Market, by Product Type, Europe (USD and EUR), 2011 - 2017
  • Figure 3: Leading Competitors in the Orthopedic Biomaterial Market, as a % of Total, Europe, 2012
  • Table 55: Leading Competitors in the Orthopedic Biomaterial Market, by Country, as a % of Total, Europe, 2012
  • Table 56: Leading Competitors in the Orthopedic Biomaterial Market, by Product Type, as a % of Total, Europe, 2012
  • Table 57: Recent Events in the Orthopedic Biomaterial Market, Europe
  • Table 58: Emerging Products in Development for the Orthopedic Biomaterial Market, Europe, 2012 - 2017

6. BONE GRAFT SUBSTITUTE MARKET

  • Figure 4: BGS Market, by Material, Europe (USD), 2011 - 2017
  • Table 59: Bone Graft Procedures, by Country, Europe, 2011 - 2017
  • Table 60: BGS Procedures, by Country, Europe, 2011 - 2017
  • Table 61: BGS Market, by Country, Europe (USD, EUR, and GBP), 2011 - 2017
  • Table 62: Bone Graft Procedures, by Material, Europe, 2011 - 2017
  • Table 63: BGS Market, by Material, Europe (USD and EUR), 2011 - 2017
  • Table 64: Average Volume of Bone Graft per Procedure, by Procedure Type, Europe , 2012
  • Table 65: Bone Graft Procedures, by Procedure Type, Europe, 2011 - 2017
  • Table 66: BGS Procedures, by Procedure Type, Europe, 2011 - 2017
  • Table 67: BGS Market, by Procedure Type, Europe (USD and EUR), 2011 - 2017
  • Figure 5: Leading Competitors in the BGS Market, as a % of Total, Europe, 2012
  • Table 68: Leading Competitors in the BGS Market, by Country, as a % of Total, Europe, 2012

7. HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

  • Figure 6: HA Viscosupplementation Market, by Number of Injections, Europe (USD), 2011 - 2017
  • Table 69: HA Viscosupplementation Treatments, by Country, Europe, 2011 - 2017
  • Table 70: HA Viscosupplementation Treatments and Injections, by Number of Injections, Europe, 2011 - 2017
  • Table 71: HA Viscosupplementation Treatments, by Anatomy, Europe, 2011 - 2017
  • Table 72: HA Viscosupplementation Market, by Country, Europe (USD, EUR, and GBP), 2011 - 2017
  • Table 73: HA Viscosupplementation Market, by Number of Injections, Europe (USD), 2011 - 2017
  • Table 74: HA Viscosupplementation Market, by Number of Injections, Europe (EUR), 2011 - 2017
  • Table 75: HA Viscosupplementation Market Growth, by Number of Injections, Europe, 2012 - 2017
  • Table 76: HA Viscosupplementation Market, by Number of Injections, as a % of Total, Europe, 2011 - 2017
  • Figure 7: Leading Competitors in the HA Viscosupplementation Market, as a % of Total, Europe, 2012
  • Table 77: Leading Competitors in the HA Viscosupplementation Market, by Country, as a % of Total, Europe, 2012

8. FRENCH ORTHOPEDIC BIOMATERIAL MARKET

  • Figure 8: BGS Market, by Material, France (USD), 2011 - 2017
  • Table 78: Bone Graft Procedures, by Material, France, 2011 - 2017
  • Table 79: Bone Graft Procedures, by Procedure Type, France, 2011 - 2017
  • Table 80: BGS Procedures, by Procedure Type, France, 2011 - 2017
  • Table 81: BGS ASPs, by Material, France (USD and EUR), 2011 - 2017
  • Table 82: BGS Market, by Material, France (USD and EUR), 2011 - 2017
  • Table 83: BGS ASPs, by Procedure Type, France (USD and EUR), 2011 - 2017
  • Table 84: BGS Market, by Procedure Type, France (USD and EUR), 2011 - 2017
  • Figure 9: HA Viscosupplementation Market, by Number of Injections, France (USD), 2011 - 2017
  • Table 85: HA Viscosupplementation Treatments and Injections, by Number of Injections, France, 2011 -2017
  • Table 86: HA Viscosupplementation Treatments, by Anatomy, France, 2011 - 2017
  • Table 87: HA Viscosupplementation Market, by Number of Injections, France (USD), 2011 - 2017
  • Table 88: HA Viscosupplementation Market, by Number of Injections, France (EUR), 2011 - 2017
  • Table 89: HA Viscosupplementation Market Growth, by Number of Injections, France, 2012 - 2017
  • Table 90: HA Viscosupplementation Market, by Number of Injections, as a % of Total, France, 2011 - 2017
  • Figure 10: Leading Competitors in the Orthopedic Biomaterial Market, as a % of Total, France, 2012
  • Table 91: Leading Competitors in the Orthopedic Biomaterial Market, by Product Type, as a % of Total, France, 2012

9. GERMAN ORTHOPEDIC BIOMATERIAL MARKET

  • Figure 11: BGS Market, by Material, Germany (USD), 2011 - 2017
  • Table 92: Bone Graft Procedures, by Material, Germany, 2011 - 2017
  • Table 93: Bone Graft Procedures, by Procedure Type, Germany, 2011 - 2017
  • Table 94: BGS Procedures, by Procedure Type, Germany, 2011 - 2017
  • Table 95: BGS ASPs, by Material, Germany (USD and EUR), 2011 - 2017
  • Table 96: BGS Market, by Material, Germany (USD and EUR), 2011 - 2017
  • Table 97: BGS ASPs, by Procedure Type, Germany (USD and EUR), 2011 - 2017
  • Table 98: BGS Market, by Procedure Type, Germany (USD and EUR), 2011 - 2017
  • Figure 12: HA Viscosupplementation Market, by Number of Injections, Germany (USD), 2011 - 2017
  • Table 99: HA Viscosupplementation Treatments and Injections, by Number of Injections, Germany, 2011 - 2017
  • Table 100: HA Viscosupplementation Treatments, by Anatomy, Germany, 2011 - 2017
  • Table 101: HA Viscosupplementation Market, by Number of Injections, Germany (USD), 2011 - 2017
  • Table 102: HA Viscosupplementation Market, by Number of Injections, Germany (EUR), 2011 - 2017
  • Table 103: HA Viscosupplementation Market Growth, by Number of Injections, Germany, 2012 - 2017
  • Table 104: HA Viscosupplementation Market, by Number of Injections, as a % of Total, Germany, 2011 - 2017
  • Figure 13: Leading Competitors in the Orthopedic Biomaterial Market, as a % of Total, Germany, 2012
  • Table 105: Leading Competitors in the Orthopedic Biomaterial Market, by Product Type, as a % of Total, Germany, 2012

10. ITALIAN ORTHOPEDIC BIOMATERIAL MARKET

  • Figure 14: BGS Market, by Material, Italy (USD), 2011 - 2017
  • Table 106: Bone Graft Procedures, by Material, Italy, 2011 - 2017
  • Table 107: Bone Graft Procedures, by Procedure Type, Italy, 2011 - 2017
  • Table 108: BGS Procedures, by Procedure Type, Italy, 2011 - 2017
  • Table 109: BGS ASPs, by Material, Italy (USD and EUR), 2011 - 2017
  • Table 110: BGS Market, by Material, Italy (USD and EUR), 2011 - 2017
  • Table 111: BGS ASPs, by Procedure Type, Italy (USD and EUR), 2011 - 2017
  • Table 112: BGS Market, by Procedure Type, Italy (USD and EUR), 2011 - 2017
  • Figure 15: HA Viscosupplementation Market, by Number of Injections, Italy (USD), 2011 - 2017
  • Table 113: HA Viscosupplementation Treatments and Injections, by Number of Injections, Italy, 2011 - 2017
  • Table 114: HA Viscosupplementation Treatments, by Anatomy, Italy, 2011 - 2017
  • Table 115: HA Viscosupplementation Market, by Number of Injections, Italy (USD), 2011 - 2017
  • Table 116: HA Viscosupplementation Market, by Number of Injections, Italy (EUR), 2011 - 2017
  • Table 117: HA Viscosupplementation Market Growth, by Number of Injections, Italy, 2012 - 2017
  • Table 118: HA Viscosupplementation Market, by Number of Injections, as a % of Total, Italy, 2011 - 2017
  • Figure 16: Leading Competitors in the Orthopedic Biomaterial Market, as a % of Total, Italy, 2012
  • Table 119: Leading Competitors in the Orthopedic Biomaterial Market, by Product Type, as a % of Total, Italy, 2012

11. SPANISH ORTHOPEDIC BIOMATERIAL MARKET

  • Figure 17: BGS Market, by Material, Spain (USD), 2011 - 2017
  • Table 120: Bone Graft Procedures, by Material, Spain, 2011 - 2017
  • Table 121: Bone Graft Procedures, by Procedure Type, Spain, 2011 - 2017
  • Table 122: BGS Procedures, by Procedure Type, Spain, 2011 - 2017
  • Table 123: BGS ASPs, by Material, Spain (USD and EUR), 2011 - 2017
  • Table 124: BGS Market, by Material, Spain (USD and EUR), 2011 - 2017
  • Table 125: BGS ASPs, by Procedure Type, Spain (USD and EUR), 2011 - 2017
  • Table 126: BGS Market, by Procedure Type, Spain (USD and EUR), 2011 - 2017
  • Figure 18: HA Viscosupplementation Market, by Number of Injections, Spain (USD), 2011 - 2017
  • Table 127: HA Viscosupplementation Treatments and Injections, by Number of Injections, Spain, 2011 - 2017
  • Table 128: HA Viscosupplementation Treatments, by Anatomy, Spain, 2011 - 2017
  • Table 129: HA Viscosupplementation Market, by Number of Injections, Spain (USD), 2011 - 2017
  • Table 130: HA Viscosupplementation Market, by Number of Injections, Spain (EUR), 2011 - 2017
  • Table 131: HA Viscosupplementation Market Growth, by Number of Injections, Spain, 2012 - 2017
  • Table 132: HA Viscosupplementation Market, by Number of Injections, as a % of Total, Spain, 2011 - 2017
  • Figure 19: Leading Competitors in the Orthopedic Biomaterial Market, as a % of Total, Spain, 2012
  • Table 133: Leading Competitors in the Orthopedic Biomaterial Market, by Product Type, as a % of Total, Spain, 2012

12. UK ORTHOPEDIC BIOMATERIAL MARKET

  • Figure 20: BGS Market, by Material, UK (USD), 2011 - 2017
  • Table 134: Bone Graft Procedures, by Material, UK, 2011 - 2017
  • Table 135: Bone Graft Procedures, by Procedure Type, UK, 2011 - 2017
  • Table 136: BGS Procedures, by Procedure Type, UK, 2011 - 2017
  • Table 137: BGS ASPs, by Material, UK (USD, EUR, and GBP), 2011 - 2017
  • Table 138: BGS Market, by Material, UK (USD, EUR, and GBP), 2011 - 2017
  • Table 139: BGS ASPs, by Procedure Type, UK (USD, EUR, and GBP), 2011 - 2017
  • Table 140: BGS Market, by Procedure Type, UK (USD, EUR, and GBP), 2011 - 2017
  • Figure 21: HA Viscosupplementation Market, by Number of Injections, UK (USD), 2011 - 2017
  • Table 141: HA Viscosupplementation Treatments and Injections, by Number of Injections, UK, 2011 - 2017
  • Table 142: HA Viscosupplementation Treatments, by Anatomy, UK, 2011 - 2017
  • Table 143: HA Viscosupplementation Market, by Number of Injections, UK (USD), 2011 - 2017
  • Table 144: HA Viscosupplementation Market, by Number of Injections, UK (EUR), 2011 - 2017
  • Table 145: HA Viscosupplementation Market, by Number of Injections, UK (GBP), 2011 - 2017
  • Table 146: HA Viscosupplementation Market Growth, by Number of Injections, UK, 2012 - 2017
  • Table 147: HA Viscosupplementation Market, by Number of Injections, as a % of Total, UK, 2011 - 2017
  • Figure 22: Leading Competitors in the Orthopedic Biomaterial Market, as a % of Total, UK, 2012
  • Table 148: Leading Competitors in the Orthopedic Biomaterial Market, by Product Type, as a % of Total, UK, 2012

APPENDIX: METHODOLOGY

APPENDIX: ACRONYMS AND INITIALISMS

  • Table 149: Acronyms and Initialisms

APPENDIX: BIBLIOGRAPHY

Show More
Pricing
Get Notified
Email me when related reports are published